Chongqing Genrix Biopharmaceutical Co Ltd Sustainability Reports
The company engages in the research, development, production, and sale of antibody drugs, focusing on monoclonal, bispecific, and polyspecific antibodies for autoimmune diseases, infectious diseases, and oncology.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG018CDC3J9
2 reports from 2024 to 2025
